A new form of CAR T kills leukemia, multiple myeloma, and sarcoma in mice, opening the door to a future off-the-shelf cancer ...
The current path to CAR-T cell therapy is, by any measure, a logistical ordeal. A patient’s immune cells must be drawn out of ...
This figure shows T cell infiltration (green) and cell death (pink) in controls (left) and test tumors from CMV-infected mice after treatment with CMV peptides. Researchers at the University of ...
According to the results of the early study, published simultaneously in the New England Journal of Medicine, 92% of patients ...
A new discovery from researchers at The University of Texas at Austin and The University of Texas MD Anderson Cancer Center helps explain why some ...
A redesigned cancer immunotherapy is showing striking early results after decades of disappointment with similar drugs.
A new wave of immuno-therapies is reshaping the fight against cancer, turning the body’s own immune system into a powerful ...
Morning Overview on MSN
Experimental prostate cancer drug shrinks tumors in early clinical trial
Several experimental prostate cancer drugs have produced striking results in early-stage clinical trials, with at least one ...
For decades, large portions of the human genome were labeled "junk DNA." New research from Western University and London ...
Add Yahoo as a preferred source to see more of our stories on Google. Lab assistant with white mice Image by Canva MIT researchers have developed an experimental mRNA-based therapy that restored key ...
Researchers at the University of California San Diego have discovered a promising new treatment approach for pancreatic cancer, one of the deadliest and most treatment-resistant forms of cancer. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results